Early to mid-stage biotechs have the technology, scientific knowledge and leadership to achieve success with early-stage funding and research but, would often benefit from with help communicating the value of their programs and how next steps build toward long-term goals, especially as development programs become more complex with progress.
Trileac Advisors supports these types of companies by clarifying the big picture, mapping out the path to long-term goals, identifying what resources are needed and when, and elucidating what needs to be true and when to revisit assumptions.
We additionally provide operational support for clients to execute next steps until they are adequately resourced.
Services include:
Many early-development-stage biotechs have clear project plans for their assets, but frequently lack cross-functional coordination mechanisms or lack representation from non-core functions (e.g., commercial, IP) during planning processes or project execution.
Trileac Advisors supports these types of companies by acting as a project lead: continually facilitating cross-functional coordination to ensure project plans are ready for execution, ensuring execution according to plan, developing robust responses to operational and strategic challenges and ensuring the right level of coordination and transparency for stakeholders and leadership.
Services include:
As biotechs initiate, or participate in, partnering or fund-raising processes, they frequently leverage third-party support that overly focuses on “quantity” through networking but critically fail by missing “quality” from communicating value of the company or underlying assets.
Trileac Advisors supports clients’ transactions by taking an “inside the company” approach and focusing on effective communication of the company’s or asset’s value, to maximize and retain interest from potential investors and partners, as well as executing on the detailed operations of the various stages of these processes, including post-deal activities.
Services include:
Copyright © 2024 Trileac Advisors L.L.C - All Rights Reserved